Clinical study data indicates that Celliant reduces pain

3 July 2009, Santa Monica, CA - Already proven to increase oxygen levels in the body, data from a new clinical study published in online journal BioMedCentral.com supports claims that Celliant reduces pain. Celliant is a specially formulated technical performance fibre designed to enhance oxygen levels in the body, aiding in comfort, healing, performance and overall wellness.

Data analysis from a clinical study conducted by Robyn MB York and Ian L. Gordon, research scientists affiliated with Long Beach VA Healthcare System and UCI Medical Center, shows that the material also has potent pain relief capabilities. In a double blind study using measurement techniques successfully employed in FDA-supervised clinical trials of pain relief medications, the magnitude of pain relief reported by participants using products enhanced with Celliant was significantly greater than that reported by participants using placebo products. Hologenix, LLC, the company behind Celliant, sponsored the trials.

"We have completed a properly designed clinical trial which shows strong results in favour of Celliant," explains Seth Casden, CEO of Hologenix, LLC. "The results are statistically significant, providing clinical proof that products enhanced with Celliant actually reduce pain."

The results are statistically significant, providing clinical proof that products enhanced with Celliant actually reduce pain. To date, much of the research conducted on Celliant has been limited to patients with diabetes, or some form of vascular impairment. However, many individuals have trouble staying active because of chronic pain - virtually everyone suffers from some sort of ache or pain during their life.

These results have obvious implications for the health and medical markets. However, Hologenix believes a broader market for their pain relieving textile exists.

"To date, much of the research conducted on Celliant has been limited to patients with diabetes, or some form of vascular impairment," explains Casden. "However, many individuals have trouble staying active because of chronic pain--virtually everyone suffers from some sort of ache or pain during their life."

In fact, this most recent study included subjects who suffered from diabetic neuropathic pain as well as a second group of non-diabetic subjects. Both groups experienced significant pain relief. The data showing a greater reduction in pain with Celliant was sufficiently strong that the research team is conducting a second, follow-up study to further measure the pain reduction and healing characteristics of Celliant.

"Personally, I was very surprised by the results. In doing these studies, you often hope for a positive result but, in this case, the data points overwhelmingly to Celliant reducing pain," stated Dr. Ian L. Gordon, PhD and head of Vascular Surgery at Long Beach VA Medical Center. "What we have here is a material that can be incorporated into any number of products, including garments, bedding, socks, bandages and athletic wear to non-invasively reduce pain. It's a very exciting moment for us as research scientists and for the medical and health community at large."

The technology behind Celliant is based on years of research regarding the effect of certain wavelengths of light on the body and wound healing. Past studies have shown that light can be used to reduce pain, speed healing, increase energy and improve overall wellness. Celliant is a polymer fibre containing optically active micro-particles, a proprietary mixture of natural materials, which scatter and reflect visible and near infrared light. Products constructed with such optically modified fibres are designed to scatter and reflect light and energy onto the underlying tissue and skin. Numerous anecdotal reports from patients with a variety of chronic pain syndromes indicate that wearing garments or sleeping on bedding containing Celliant led to dramatic improvement or complete resolution of pain. The goal of this study was to scientifically confirm and measure these results.

Hologenix, LLC, is currently conducting three additional clinical studies to further measure the effects of Celliant on sleep, athletic performance and health.

About Celliant

Celliant is a specially formulated fibre that is knit or woven into fabrics used in garments and bedding materials. Products containing Celliant have been clinically proven to enhance oxygen levels in the body and reduce pain. Increased oxygen levels have been clinically proven to relieve pain, promote quicker healing, improve sleep quality, heighten athletic performance and improve overall wellness.

Products enhanced with Celliant have been clinically proven to relieve pain, increase comfort and aid in healing by increasing oxygen levels and helping to regulate body temperature. Celliant is now available in a variety of products for the sleep, sport, health and life markets.

About Hologenix

Hologenix, LLC, maker of Celliant, is committed to creating, discovering and marketing products that enhance people's lives through pain relief, increased comfort and improved overall well-being. The research that led to the creation of Celliant began in the 1990s when a team of pioneers in the field of alternative medicine visited Asia and observed the use of several natural substances that were thought to have a positive effect on health. After seven years of research and study, the team was able to integrate some of these materials into fabrics that could be made into apparel, bedding and medical products. Hologenix was founded in order to commercialize and bring this material, known as Celliant, to market. The Celliant formulation is patent protected.